QLIFE
Actualité - Funding

Laureates of the prematuration grants 2023

03/19/2024
Partager
In 2023, we funded two prematuration projects which will allow to develop innovative projects with the will to develop technology transfer.
Congratulations to all of them!
Prematuration 2021

prematuration laureates 2023

 

Discover the funded projects

  • Viacheslav Mazlin (ESPCI) - Transmission Imager for Ocular Surgery prognosis and follow-up | Recently (2022), we invented a new optical sectioning technology – Optical Transmission Tomography (OTT). OTT uses a common-path interferometer design, which makes the imaging more robust and significantly reduces the device cost down to a few thousands euros. In this project we aim to implement this technology to eye imaging – the medical field of our expertise. OTT can provide unique view of the eye merging the high cell-level resolution (1 μm) with large field spanning across 5 mm. This view would be particular valuable in refractive surgery, where a need exists for both large view analysis of ocular shapes and cell counting for avoiding complications (e.g. Fuch’s endothelial dystrophy). Beyond the device development the project concerns imaging of the patient cohorts and release of the first product for clinical research. We have the long and positive history of collaboration with doctors at 15-20 National Eye Hospital, Paris as well as major clinical centers abroad. The beneficiary start-up company has been established.
  • Jean Baudry (ESPCI)REVOBIOM: Leading the upcoming microbiome revolution | Microorganisms are at the heart of the ecological, food, energy and health issues of our time. Although used in many industrial processes (fermentation, production of antibiotics, enzymes, biofuels, etc.), they are generally used in isolation, which presents several problems: lack of stability, use of genetic engineering (OGM), difficulty of accessing complex functions. In nature, complex functions (fermentation, bio-stimulation, bio-control, degradation of pollutants: pesticide, plastic, hydrocarbons, etc.) are carried out by microbial communities, today difficult to establish and exploit in the industry. Thanks to its disruptive technology, based on digital millifluidics, REVOBIOM offers an innovative solution to develop stable and effective natural microbial products for the agri-food, agriculture, ecology, energy and health.